ArticleMolecular therapy. Methods & clinical development2025

AAV-mediated peripheral scFv's administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy.

Sebica Katel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.